Dae Gon Ha

Stock Analyst at Stifel

(2.37)
# 2,427
Out of 5,182 analysts
55
Total ratings
35.56%
Success rate
4.52%
Average return

Stocks Rated by Dae Gon Ha

Mirum Pharmaceuticals
Feb 26, 2026
Maintains: Buy
Price Target: $98$125
Current: $92.48
Upside: +35.16%
Abeona Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $21$20
Current: $5.34
Upside: +274.53%
Editas Medicine
Dec 13, 2024
Downgrades: Hold
Price Target: $11$3
Current: $2.89
Upside: +3.81%
Soleno Therapeutics
Oct 1, 2024
Maintains: Buy
Price Target: $59$74
Current: $52.75
Upside: +40.28%
Fulcrum Therapeutics
Sep 12, 2024
Downgrades: Hold
Price Target: $22$3
Current: $7.72
Upside: -61.14%
Intellia Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $80$64
Current: $13.04
Upside: +390.80%
Krystal Biotech
Sep 11, 2024
Maintains: Buy
Price Target: $204$220
Current: $272.75
Upside: -19.34%
Ultragenyx Pharmaceutical
May 31, 2024
Maintains: Buy
Price Target: $124$127
Current: $23.99
Upside: +429.39%
Rocket Pharmaceuticals
Sep 13, 2023
Reiterates: Buy
Price Target: $48
Current: $3.49
Upside: +1,275.36%
Prime Medicine
Apr 18, 2023
Initiates: Buy
Price Target: $18
Current: $3.67
Upside: +390.46%
Maintains: Buy
Price Target: $12$7
Current: $2.04
Upside: +243.14%
Downgrades: Hold
Price Target: $86$52
Current: $10.25
Upside: +407.32%
Maintains: Buy
Price Target: $23$25
Current: $85.20
Upside: -70.66%
Upgrades: Buy
Price Target: $12$16
Current: $14.49
Upside: +10.42%
Initiates: Buy
Price Target: $285
Current: $29.95
Upside: +851.59%
Initiates: Buy
Price Target: $20
Current: $1.49
Upside: +1,242.28%
Downgrades: Neutral
Price Target: n/a
Current: $10.08
Upside: -
Initiates: Neutral
Price Target: n/a
Current: $40.95
Upside: -
Initiates: Neutral
Price Target: n/a
Current: $8.90
Upside: -
Initiates: Buy
Price Target: $12
Current: $1.61
Upside: +645.34%
Maintains: Outperform
Price Target: $600$490
Current: $20.39
Upside: +2,303.14%